Nephrologists Transforming Dialysis Safety

Targeting Zero Infections: Hepatitis C Detection, Prevention, and Treatment

Thursday, December 6, 2018 12:00 PM - 1:00 PM

Register for the December 6, 2018, webinar - Targeting Zero Infections: Hepatitis C Detection, Prevention, and Treatment here.

Thursday, December 6, 2018 | 12:00 PM-1:00 PM EST

Please join us for this complimentary webinar!

Preventing infections is critical for those individuals receiving dialysis. This complimentary webinar will review the critical role that nephrologists and dialysis professionals have in preventing infections and diagnosing infections when they occur. Hepatitis C is associated with increased mortality among patients in the US on hemodialysis with an overall prevalence of 14%. Hepatitis C has a 10-fold higher prevalence in hemodialysis patients than in the general population. The implementation of the practices described in this webinar will positively impact the infection prevention process related to hepatitis C in your facility.

Webinar Highlights:

Upon completion of this session, the participant will be able to:

  • Review the epidemiology of hepatitis C in individuals with ESRD
  • Demonstrate understanding of the need for timely monitoring and surveillance of individuals on dialysis for the presence of hepatitis C.
  • Discuss the process for hepatitis C detection, as well as what to do if a positive seroconversion is detected.
  • Discuss the procedures necessary to prevent the spread of hepatitis C within the dialysis facility.
  • Summarize the 2018 KDIGO guidance for the detection and treatment of hepatitis C for individuals undergoing dialysis treatment.
  • Apply any modifications needed in either the detection, prevention, referral, and treatment for hepatitis C within your dialysis facility.

Moderators

Alan S. Kliger, MD

Clinical Professor of Medicine, Yale University School of Medicine and
Vice President, Medical Director of Clinical Integration, Yale New Haven Health System
New Haven, CT

Susie Stark

NTDS Director
American Society of Nephrology
Washington, DC

Speakers

Paul Martin, MD

Member, NTDS Current & Emerging Threats Workgroup
Chief, Division of Hepatology; Professor of Medicine
University of Miami(NCEZID)
Miller School of Medicine
Miami, FL

Paul Palevsky, MD, FASN

Member, NTDS Current & Emerging Threats Workgroup
Chief, Renal Section
VA Pittsburgh Healthcare System
Pittsburgh, PA

Disclosures

All faculty, planner, and staff disclosures may be viewed here.

Target Audience

  • Medical Directors
  • Nephrologists
  • Nurses
  • Technicians
  • Nephrology Fellows
  • Other

Registration

To register for this webinar, visit here.

Accreditation and Continuing Education Credit Designation Statements

CME Credit

The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Nephrology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit
Joint Accreditation Provider

In support of improving patient care, this activity has been planned and implemented by the University of Minnesota, Interprofessional Continuing Education and the American Society of Nephrology. University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is awarded up to 1.0 ANCC contact hour.